| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K24690302 |
| PharmacoGx | BRD-K24690302 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EIF3M | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | RP11-724O16.1 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | PPP2R5B | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | TATDN2 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | PLD6 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | RP11-26J3.4 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | CYB5R1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | JADE2 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | CS | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | ZBTB39 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
